Science Explorer Back to mapMap
Discussion
Company · Kiel · Germany

GALENpharma (Germany)

galenpharma.de/startseiteROR OpenAlex
Research works
2
▼ 100% vs 2018-21
Citations
204
95.8 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
44%
world 40%
International
53%
world 18%
GALENpharma (Germany)

Not ranked overall: GALENpharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GALENpharma (Germany) work in?

In all years, 85% of research at GALENpharma (Germany) is in Life Sciences, 15% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Immunology and Microbiology (40%), Chemistry (15%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 85.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 45.0% of its workImmunology and Microbiology: 1 fractional works · 40.0% of its workPhysical Sciences: 0 fractional works · 15.0% of its workChemistry: 0 fractional works · 15.0% of its workALL ITS WORKGALENpharma(Germany)2fractional works, all years
Life Sciences85%Physical Sciences15%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology145.0%
    2. Immunology and Microbiology140.0%
    1. Chemistry015.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from GALENpharma (Germany)?

The most cited paper from GALENpharma (Germany) is "IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma" (Zhi‐Zhang Yang, Deanna M. Grote, Steven C. Ziesmer et al., 2012), with 308 citations. Next come "Involvement of Galectin-9 in Guinea Pig Allergic Airway Inflammation" (32) and "Galectin-9 Changes Its Function to Maintain Homeostasis" (3).

Most cited papers
#PaperReleasedCitations
1 IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma Zhi‐Zhang Yang, Deanna M. Grote, Steven C. Ziesmer et al. · Journal of Clinical Investigation Open access 19 Mar 2012 308
2 Involvement of Galectin-9 in Guinea Pig Allergic Airway Inflammation Hitomi Yamamoto, Yumiko Kashio, Hiroki Shoji et al. · International Archives of Allergy and Immunology 2007 32
3 Galectin-9 Changes Its Function to Maintain Homeostasis Mitsuomi Hirashima, Toshiro Niki, Tsutomu Masaki · Trends in Glycoscience and Glycotechnology Open access 2018 3
4 Intracellular Galectin-9 Controls Dendritic Cell Function by Maintaining Plasma Membrane Rigidity Laia Querol Cano, Oya Tagit, Anne van Duffelen et al. · SSRN Electronic Journal PreprintOpen access 2019 1
All 4 most cited papers, with filters and sorting

Which research topics does GALENpharma (Germany) publish most on?

By volume: Galectins and Cancer Biology, Redox biology and oxidative stress, Free Radicals and Antioxidants and Macrophage Migration Inhibitory Factor.

Galectins and Cancer Bio…0Galectins and Cancer Biology: 0 fractional worksRedox biology and oxidative stress: 0 fractional worksFree Radicals and Antioxidants: 0 fractional worksMacrophage Migration Inh…0Macrophage Migration Inhibitory Factor: 0 fractional worksElectron Spin Resonance …0Electron Spin Resonance Studies: 0 fractional worksIL-33, ST2, and ILC Pathways: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksSignaling Pathways in Disease: 0 fractional worksStudies on Chitinases and Chitosanases: 0 fractional works
ImmunologyMolecular BiologyOrganic ChemistryBiophysics

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Galectins and Cancer Biology Immunology 0 works
  2. 2 Redox biology and oxidative stress Molecular Biology 0 works
  3. 3 Free Radicals and Antioxidants Organic Chemistry 0 works
  4. 4 Macrophage Migration Inhibitory Factor Immunology 0 works
  5. 5 Electron Spin Resonance Studies Biophysics 0 works
  6. 6 IL-33, ST2, and ILC Pathways Immunology 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Signaling Pathways in Disease Molecular Biology 0 works
  9. 9 Studies on Chitinases and Chitosanases Molecular Biology 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.8%not open56.2%

World: 40% of research is openly available.

with international co-authors53.2%domestic only46.8%

World: 18% is written across borders.

How has GALENpharma (Germany)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

200520102015

Other research institutions in Kiel

All research institutions in Kiel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GALENpharma (Germany). Posts are plain text and can be reported.